NIMBLE Diagnostics

NIMBLE Diagnostics

Private
BadalonaHealthcare & Life Scienceshttps://dxnimble.com

Last Round

Series A

May 18, 2025

Total Funding Raised

$15.81M

Company Overview

NIMBLE Diagnostics is a medical technology company developing a non-invasive diagnostic device for the detection of cardiovascular conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

stent monitoringnon-invasive monitoringmedtechdiagnostic devicepoint-of-care devicePOC devicestent blockage detectionin-stent restenosiscardiology devicemicrowave spectrometryangiography alternativestent fracture detectionhealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NIMBLE Diagnostics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NIMBLE Diagnostics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMay 18, 2025
GrantOct 31, 2023
GrantApr 26, 2023
SeedJan 18, 2023
SeedApr 19, 2022

Key People

Founding team and executive leadership

Susana Amorós Garcia de Valdecasas

Chief Technology Officer

Executive Team

NIMBLE Diagnostics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 29, 2025

    Developing a first-of-its-kind microwave-based medical device.

NIMBLE Diagnostics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NIMBLE Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NIMBLE Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBadalona
Employee Range17
Year Founded2022
Last FundingMay 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.